A P/S near 5x for a company with a -34.7% net margin implies investors are capitalizing a future margin recovery that the reported quarters do not yet show. The P/B of 3.84 is elevated relative to a balance sheet whose equity is largely cash, suggesting the market assigns meaningful value to the MRAM franchise beyond book assets. Without a peer P/E baseline that is meaningful, the valuation rests on forward assumptions investors should monitor closely.

The stability of gross margin indicates the MRAM product line maintains consistent unit economics, which is the most durable positive in the reported data. The deterioration below the gross line is driven by operating expense growth, pointing to negative operating leverage that revenue reacceleration has not offset. Earning power should be judged on operating margin trajectory rather than gross margin alone.

Negative ROIC across the full window suggests the invested capital base, including the cash balance, is not generating operating returns above its cost. The swing in ROE tracks net income rather than any change in balance sheet efficiency, so the decline reflects deteriorating earnings. Returns would need sustained margin repair to turn positive, and investors should monitor whether the most recent quarter marks a trend rather than a single-period dip.

The decline in current and quick ratios reflects cash consumption and rising current liabilities rather than any threat to solvency, since both ratios remain well above conventional comfort levels. Under severe stress the quick ratio of 2.65 provides a meaningful buffer, though the downward trend over ten quarters suggests the cash runway should be tracked against operating burn. The data does not show inventory dependence beyond what the DIO figures already indicate.